Explores how Rehmannia glutinosa mitigates liver toxicity from Tripterygium wilfordii, suggesting new therapeutic approaches.
Background: Tripterygium wilfordii Hook. F. (TW) has significant anti-inflammatory, anti-tumor, and immunosuppressive effects, and is often used in the treatment of rheumatic immune diseases, inflammation, and tumors; however, its liver toxicity is also prominent. Combination treatment with Rehmannia glutinosa (Gaertn.) DC (RG) and TW for detoxification originates from the Qingluotongbi formula and are also representative of a combination of strengthening the body’s resistance to attenuation (Fuzheng Zhidu). Objective: This study aimed to explore the protective effect of RG against TW-induced liver injury and its regulatory mechanism of mitophagy to explain the connotation of combination of strengthening body resistance to attenuation. Materials and Methods: After the administration of RG and TW and their main and active ingredients (triptolide [TP] and catalpol [CAT]), C57BL/6J mice and HL7702 cells were tested for liver pathological changes, liver function indicators, and mitophagy index. The protein and gene expression of the PTEN-induced putative kinase 1 (PINK1)/Parkin pathway were analyzed. In HL7702 cells, PINK1 mRNA was knocked down using siRNA to verify the role of the PINK1/Parkin pathway in mitophagy regulation. Results: RG/CAT reduced the pathological injury and alanine aminotransferase, aspartate aminotransferase, and lactate dehydrogenase levels, while reversing the protein and gene levels of microtubule-associated proteins 1A/1B-light chain 3, sequestosome-1, and dynamin-related protein 1 and inhibiting the PINK1/Parkin pathway caused by TW/TP. Knockdown of the PINK1/Parkin pathway in vitro alleviates TP-induced hepatotoxicity in HL7702 cells. Conclusions: RG inhibited excessive mitophagy to reduce TW-induced hepatotoxicity by downregulating the PINK1/Parkin pathway, providing research support for explaining the connotation of RG’s combination of strengthening the body resistance and attenuating the hepatotoxicity of TW.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: